Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guanzhang Li

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Chinese Neurosurgical Journal|February 3, 2021
A novel gene signature based on five immune checkpoint genes predicts the survival of gliomaWei Zhang, You Zhai, Guanzhang Li, et al.
American Journal of Cancer Research|January 9, 2020
CAR-armed cell therapy for gliomasYou Zhai, Guanzhang Li, Tao Jiang, et al.
Frontiers in Oncology|November 12, 2021
NK Cell-Based Immunotherapy and Therapeutic Perspective in GliomasChangqing Pan, You Zhai, Guanzhang Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 20, 2019
Transcriptomic Profiling Identifies a DNA Repair-Related Signature as a Novel Prognostic Marker in Lower Grade GliomasFan Zeng, Xiu Liu, Kuanyu Wang, et al.
Scientific Reports|October 29, 2020
A new glioma grading model based on histopathology and Bone Morphogenetic Protein 2 mRNA expressionKaijia Zhou, Zheng Zhao, Shouwei Li, et al.
Chinese Neurosurgical Journal|April 2, 2021
High-dose radiation associated with improved survival in IDH-wildtype low-grade gliomaShuai Liu, Yanwei Liu, Guanzhang Li, et al.
BMC Neurology|November 10, 2021
FXYD2 mRNA expression represents a new independent factor that affects survival of glioma patients and predicts chemosensitivity of patients to temozolomideKaijia Zhou, Tao Jiang, Yanwei Liu, et al.
Oncology Letters|December 7, 2019
Receptor tyrosine kinase expression in high-grade gliomas before and after chemoradiotherapyKuanyu Wang, Ruoyu Huang, Chenxing Wu, et al.
Frontiers in Cell and Developmental Biology|October 10, 2022
Corrigendum: Comprehensive analysis of the clinical and biological significances of endoplasmic reticulum stress in diffuse gliomasRuoyu Huang, Guanzhang Li, Kuanyu Wang, et al.
The Oncologist|March 9, 2021
Plasminogen Activator Urokinase Receptor Implies Immunosuppressive Features and Acts as an Unfavorable Prognostic Biomarker in GliomaFan Zeng, Guanzhang Li, Xiu Liu, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Chinese Neurosurgical Journal|February 3, 2021
A novel gene signature based on five immune checkpoint genes predicts the survival of gliomaWei Zhang, You Zhai, Guanzhang Li, et al.
American Journal of Cancer Research|January 9, 2020
CAR-armed cell therapy for gliomasYou Zhai, Guanzhang Li, Tao Jiang, et al.
Frontiers in Oncology|November 12, 2021
NK Cell-Based Immunotherapy and Therapeutic Perspective in GliomasChangqing Pan, You Zhai, Guanzhang Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 20, 2019
Transcriptomic Profiling Identifies a DNA Repair-Related Signature as a Novel Prognostic Marker in Lower Grade GliomasFan Zeng, Xiu Liu, Kuanyu Wang, et al.
Scientific Reports|October 29, 2020
A new glioma grading model based on histopathology and Bone Morphogenetic Protein 2 mRNA expressionKaijia Zhou, Zheng Zhao, Shouwei Li, et al.
Chinese Neurosurgical Journal|April 2, 2021
High-dose radiation associated with improved survival in IDH-wildtype low-grade gliomaShuai Liu, Yanwei Liu, Guanzhang Li, et al.
BMC Neurology|November 10, 2021
FXYD2 mRNA expression represents a new independent factor that affects survival of glioma patients and predicts chemosensitivity of patients to temozolomideKaijia Zhou, Tao Jiang, Yanwei Liu, et al.
Oncology Letters|December 7, 2019
Receptor tyrosine kinase expression in high-grade gliomas before and after chemoradiotherapyKuanyu Wang, Ruoyu Huang, Chenxing Wu, et al.
Frontiers in Cell and Developmental Biology|October 10, 2022
Corrigendum: Comprehensive analysis of the clinical and biological significances of endoplasmic reticulum stress in diffuse gliomasRuoyu Huang, Guanzhang Li, Kuanyu Wang, et al.
The Oncologist|March 9, 2021
Plasminogen Activator Urokinase Receptor Implies Immunosuppressive Features and Acts as an Unfavorable Prognostic Biomarker in GliomaFan Zeng, Guanzhang Li, Xiu Liu, et al.
Pageof 9